Related references
Note: Only part of the references are listed.The recent outbreaks of human coronaviruses: A medicinal chemistry perspective
Thanigaimalai Pillaiyar et al.
MEDICINAL RESEARCH REVIEWS (2021)
Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection
Jia-Tsrong Jan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
A fully automated crystallization apparatus for small protein quantities
Ryuichi Kato et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2021)
Targeting the Main Protease of SARS-CoV-2: From the Establishment of High Throughput Screening to the Design of Tailored Inhibitors
Julian Breidenbach et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)
A Comparative Analysis of SARS-CoV-2 Antivirals Characterizes 3CLpro Inhibitor PF-00835231 as a Potential New Treatment for COVID-19
Maren de Vries et al.
JOURNAL OF VIROLOGY (2021)
A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication
Shin-ichiro Hattori et al.
NATURE COMMUNICATIONS (2021)
Recent discovery and development of inhibitors targeting coronaviruses
Thanigaimalai Pillaiyar et al.
DRUG DISCOVERY TODAY (2020)
A new coronavirus associated with human respiratory disease in China
Fan Wu et al.
NATURE (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia
Qun Li et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs
Sangeun Jeon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
Wenhao Dai et al.
SCIENCE (2020)
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
Linlin Zhang et al.
SCIENCE (2020)
Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19
Robert L. Hoffman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Effect of Osmolality on the Pharmacokinetic Interaction between Apple Juice and Atenolol in Rats
Yuta Funai et al.
DRUG METABOLISM AND DISPOSITION (2019)
Modulating the selectivity of matriptase-2 inhibitors with unnatural amino acids
Catherine St-Georges et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
-Ketobenzothiazole Serine Protease Inhibitors of Aberrant HGF/c-MET and MSP/RON Kinase Pathway Signaling in Cancer
Zhenfu Han et al.
CHEMMEDCHEM (2016)
An Overview of Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy
Thanigaimalai Pillaiyar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Chemistry informer libraries: a chemoinformatics enabled approach to evaluate and advance synthetic methods
Peter S. Kutchukian et al.
CHEMICAL SCIENCE (2016)
From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design
Rolf Hilgenfeld
FEBS JOURNAL (2014)
Design and synthesis of new tripeptide-type SARS-CoV 3CL protease inhibitors containing an electrophilic arylketone moiety
Sho Konno et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Design, synthesis, and biological evaluation of novel dipeptide-type SARS-CoV 3CL protease inhibitors: Structure-activity relationship study
Pillaiyar Thanigaimalai et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Development of potent dipeptide-type SARS-CoV 3CL protease inhibitors with novel P3 scaffolds: Design, synthesis, biological evaluation, and docking studies
Pillaiyar Thanigaimalai et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Autoprocessing mechanism of severe acute respiratory syndrome coronavirus3C-like protease (SARS-CoV 3CLpro) from its polyproteins
Tomonari Muramatsu et al.
FEBS JOURNAL (2013)
Towards automated crystallographic structure refinement with phenix.refine
Pavel V. Afonine et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2012)
Design and Synthesis of Potent, Selective Inhibitors of Matriptase
Eloic Colombo et al.
ACS MEDICINAL CHEMISTRY LETTERS (2012)
Avogadro: an advanced semantic chemical editor, visualization, and analysis platform
Marcus D. Hanwell et al.
JOURNAL OF CHEMINFORMATICS (2012)
Overview of the CCP4 suite and current developments
Martyn D. Winn et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2011)
Differential Effect of Grapefruit Juice on Intestinal Absorption of Statins Due to Inhibition of Organic Anion Transporting Polypeptide and/or P-glycoprotein
Yoshiyuki Shirasaka et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
XDS
Wolfgang Kabsch
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
Maturation Mechanism of Severe Acute Respiratory Syndrome (SARS) Coronavirus 3C-like Proteinase
Chunmei Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
New developments for the design, synthesis and biological evaluation of potent SARS-CoV 3CLpro inhibitors
Thomas Regnier et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Development of broad-spectrum halomethyl ketone inhibitors against coronavirus main protease 3CLpro
Usman Bacha et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2008)
Effect of P-glycoprotein expression levels on the concentration-dependent permeability of drugs to the cell membrane
Yoshiyuki Shirasaka et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Phaser crystallographic software
Airlie J. McCoy et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2007)
Synthesis of glutamic acid and glutamine peptides possessing a trifluoromethyl ketone group as SARS-CoV 3CL protease inhibitors
Magne O. Sydnes et al.
TETRAHEDRON (2006)
DrugBank: a comprehensive resource for in silico drug discovery and exploration
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2006)
The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity
N Barretto et al.
JOURNAL OF VIROLOGY (2005)
The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme
HA Lindner et al.
JOURNAL OF VIROLOGY (2005)
Coot:: model-building tools for molecular graphics
P Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
C Drosten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Conservation of substrate specificities among coronavirus main proteases
A Hegyi et al.
JOURNAL OF GENERAL VIROLOGY (2002)
Structure-based design of ketone-containing, tripeptidyl human rhinovirus 3C protease inhibitors
PS Dragovich et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2000)
Share Paper
